Search by keyword or code

Companies:

Articles:

Newsletter

Get notified of the latest news, interviews and stock alerts. It's free to sign up and you can leave at any time. We don't spam.

Email

Australia
Canada
USA
UK
China
Germany

Hot Topics
Latest
Top Stocks
Asx 200
Ipos
Videos
Podcast

Australia
Canada
USA
UK
China
Germany

Stock summary

Search by keyword or code

Companies:

Argent Biopharma Limited (ASX: RGT)

Company news

Cover Image for Argent BioPharma signs manufacturing partnership with ECCPharm for emerging cannabinoid therapies

Argent BioPharma signs manufacturing partnership with ECCPharm for emerging cannabinoid therapies

March 5, 2025

0 - 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

main menu

Hot Topics
Latest
Top Stocks
ASX 200
IPOs
Videos
Podcast

sectors

Mining & Resources
Biotech & Pharma
Technology
Oil, Gas & Energy
Industrials & Juniors

tools

Stock summary
ASX announcements
Volume stocks
Director trades
Shorted stocks
Upcoming dividends
Sector tracker
Market data
Ultimate guides
Full list ASX stocks

other

Advertise
About
Glossary
Trading calendar
Terms
Privacy
Contact

Newsletter

Get the latest market news, interviews and stock alerts.

Email

International Editions

Australia
Canada
USA
UK
China
Germany

Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.

Newsletter

Get the latest market news, interviews and stock alerts.

Email

Copyright 2025 Small Caps. All rights reserved.

Follow us: